Oxymorphone Extended-Release Tablets (Opana ER) For the Management of Chronic Pain: A Practical Review for Pharmacists

Affiliations

David S Craig. P T. 2010 Jun.

. 2010 Jun;35(6):324-57.

¹ Dr. Craig is a Clinical Pharmacist Specialist at H. Lee Moffitt Cancer Center and Research Institute in Tampa, Florida.

No abstract available

Keywords: chronic pain; opioid; opioid rotation; opioid switching; oxymorphone.

References

1. Briggs M, Closs SJ, Marczewski K, Barratt J. A feasibility study of a combined nurse/pharmacist–led chronic pain clinic in primary care. Qual Prim Care. 2008;16:91–94. - PubMed
1. Kroner BA, Billups SJ, Garrison KM, et al. Actual versus projected cost avoidance for clinical pharmacy specialist-initiated medication conversions in a primary care setting in an integrated health system. J Manag Care Pharm. 2008;14:155–163. - PMC - PubMed
1. Coluzzi F, Pappagallo M. Opioid therapy for chronic noncancer pain: Practice guidelines for initiation and maintenance of therapy. Minerva Anestesiol. 2005;71:425–433. - PubMed
1. Chou R, Fanciullo GJ, Fine PG, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10:113–130. - PMC - PubMed
1. Chou R, Ballantyne JC, Fanciullo GJ, et al. Research gaps on use of opioids for chronic noncancer pain: Findings from a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. J Pain. 2009;10:147–159. - PubMed